Platelet aggregation may not be a prerequisite for collagen-stimulated platelet generation of nitric oxide

By determining the sum of the supernatant concentrations of nitrite and nitrate the stimulated generation of nitric oxide (NO) by human washed platelets induced by a range of fibrillar collagen concentrations (0.0156–25 μg ml −1) was investigated. Platelet serotonin (5-hydroxytryptamine, 5-HT) efflu...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1473; no. 2; pp. 286 - 292
Main Authors Smith, Christopher C.T, Stanyer, Lee, Cooper, Michael B, Betteridge, D.John
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 27.12.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:By determining the sum of the supernatant concentrations of nitrite and nitrate the stimulated generation of nitric oxide (NO) by human washed platelets induced by a range of fibrillar collagen concentrations (0.0156–25 μg ml −1) was investigated. Platelet serotonin (5-hydroxytryptamine, 5-HT) efflux and platelet aggregation were also measured. Under resting conditions (0 μg ml −1 collagen) platelet NO release was equivalent to 1.06±0.17 nmol per 10 8 platelets. Maximal NO release, equivalent to 2.1±0.37 nmol per 10 8 platelets, was observed with only 0.0625 μg ml −1 collagen ( P<0.02, stimulated vs. resting release), higher collagen concentrations producing no further increases in platelet NO output. By contrast, maximal platelet aggregation and 5-HT efflux did not occur until collagen concentrations of 2.5 μg ml −1 and 10–25 μg ml −1, respectively, had been achieved. l-NAME (1 mmol l −1) and l-NMMA (1 mmol l −1) inhibited stimulated platelet NO generation by 78±6% and 72%, respectively. Contrasting with fibrillar collagen, fibrillar β-amyloid protein had no effect on platelet NO generation, or on 5-HT efflux or aggregation. These data perhaps indicate that NO generation by human platelets is stimulated by concentrations of fibrillar collagen insufficient to elicit an aggregatory response. Such a mechanism could operate in vivo to inhibit platelet aggregation which might otherwise be induced by low concentrations of circulating agonists.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0304-4165
0006-3002
1872-8006
1878-2434
DOI:10.1016/S0304-4165(99)00202-0